Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 328

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 328
---
: the remaining balance of the loan will provide OmnigenicsAI the option to receive 200 products annually for the first three years for pilot and sales initiatives, valued at a baseline price of $400 per unit, further reducing the remaining debt of $240,000 owed to Parent; •Sales Targets and Termination: OmnigenicsAI must meet minimum sales targets by the end of year three, with failure to achieve these allowing MultiplAI to terminate the Reseller License Agreement; •Territorial Exclusivity: the license grants OmnigenicsAI exclusive rights to Latin America, with a right of first offer for MultiplAI to commercialize in territories where OmnigenicsAI does not pursue the product; and •Joint Sales and Marketing Obligations: OmnigenicsAI will be responsible for building a regional sales infrastructure, and both companies will establish a sales committee to monitor progress against a jointly defined sales plan. See “ Unaudited Pro Forma Combined Financial Information — Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of June 30, 2024.” EarlyBird Engagement Letter On October 17, 2022, APx and EarlyBird entered into a business combination advisory agreement (the “BCAA”) and a placement agency agreement (the “Placement Agreement”). The BCAA provided for a fee to EarlyBird equal to $2,000,000 payable upon (and conditioned upon) the closing of a business combination, up to 25% of which would be credited to any amounts due under the Placement Agreement. The BCAA contains customary expense reimbursement and indemnification provisions, and is terminable only by written agreement of both parties. The Placement Agreement provided for a fee to EarlyBird, in the event of a capital raise conducted in connection with a business combination, equal to 4.5% of the aggregate equity amount funded by investors contacted by EarlyBird, and 2.5% of the aggregate debt financing amount, including secured and convertible debt, funded by investors contacted by EarlyBird, payable upon (and conditioned upon) the closing of such business combination and related capital raise. The Placement Agreement contains customary expense reimbursement and indemnification provisions, and could be terminated by either party with 30 days’ notice. On August 22, 2023, APx and EarlyBird entered into a letter agreement (the “Letter Agreement”), terminating the Placement Agreement and amending the BCAA (such amended BCAA, the “EarlyBird Engagement Letter”). Pursuant to the terms of the Early